Boutique Biotech • 0 implied HN points • 13 Jun 23
- PDS Biotechnology faced a drop in stock value after uncertainty surrounding response rates.
- The company reported a 41.2% confirmed/unconfirmed overall response rate.
- Consider the buy opportunity with PDS Biotechnology or watch from the sidelines.